Time between milestone events in the Alzheimer's disease amyloid cascade

•The time-from-Aβ pathology measure identifies early signs of disease progression.•Increases in tau pathology and cognitive dysfunction occur 4–8 years prior to Aβ-positivity.•Slowing the spread of tau pathology and cognitive decline may require treatment prior to significant Aβ pathology. Estimate...

Full description

Saved in:
Bibliographic Details
Published in:NeuroImage (Orlando, Fla.) Vol. 227; p. 117676
Main Authors: Insel, Philip S., Donohue, Michael C., Berron, David, Hansson, Oskar, Mattsson-Carlgren, Niklas
Format: Journal Article
Language:English
Published: United States Elsevier Inc 15-02-2021
Elsevier Limited
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•The time-from-Aβ pathology measure identifies early signs of disease progression.•Increases in tau pathology and cognitive dysfunction occur 4–8 years prior to Aβ-positivity.•Slowing the spread of tau pathology and cognitive decline may require treatment prior to significant Aβ pathology. Estimate the time-course of the spread of key pathological markers and the onset of cognitive dysfunction in Alzheimer's disease. In a cohort of 335 older adults, ranging in cognitive functioning, we estimated the time of initial changes of Aβ, tau, and decreases in cognition with respect to the time of Aβ-positivity. Small effect sizes of change in CSF Aβ42 and regional Aβ PET were estimated to occur several decades before Aβ-positivity. Increases in CSF tau occurred 7–8 years before Aβ-positivity. Temporoparietal tau PET showed increases 4–5 years before Aβ-positivity. Subtle cognitive dysfunction was observed 4–6 years before Aβ-positivity. Increases in tau and cognitive dysfunction occur years before commonly used thresholds for Aβ-positivity. Explicit estimates of the time for these events provide a clearer picture of the time-course of the amyloid cascade and identify potential windows for specific treatments.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1053-8119
1095-9572
DOI:10.1016/j.neuroimage.2020.117676